Miles Priebe
Family · Pinckneyville, ILNPI 1831642164
Payments from drug & device makers
Across 281 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$767
- AstraZeneca$709
- Novo Nordisk$619
- AbbVie$566
- Novartis$420
- Sumitomo Pharma America, Inc.$261
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,898100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 44 | $767 |
| AstraZeneca | 33 | $709 |
| Novo Nordisk | 42 | $619 |
| AbbVie | 38 | $566 |
| Novartis | 19 | $420 |
| Sumitomo Pharma America, Inc. | 17 | $261 |
| Pfizer | 15 | $256 |
| Amgen | 13 | $240 |
| Mylan Specialty L.p. | 11 | $167 |
| Boehringer Ingelheim | 9 | $144 |
| Merck | 5 | $109 |
| Vanda Pharmaceuticals Inc. | 3 | $103 |
| Bayer | 7 | $103 |
| Viatris Specialty LLC | 4 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $39 |
| Exact Sciences | 2 | $34 |
| GSK | 2 | $34 |
| Daiichi Sankyo Inc. | 1 | $30 |
| Grifols USA, LLC | 2 | $28 |
| Seqirus USA Inc | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $16 |
| Organogenesis Inc. | 1 | $16 |
| Abbott | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$125
How this compares
$4,898 in reported general payments places this provider in the 90th percentile of 4,941 family providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 94 | $97,773 |
| EliquisApixaban | 80 | $86,329 |
| OzempicSemaglutide | 39 | $38,053 |
| FarxigaDapagliflozin Propanediol | 34 | $37,931 |
| TrulicityDulaglutide | 31 | $33,252 |
| RybelsusSemaglutide | 20 | $28,811 |
| JardianceEmpagliflozin | 15 | $23,746 |
| MyrbetriqMirabegron | 36 | $20,797 |
| XareltoRivaroxaban | 13 | $16,944 |
| GemtesaVibegron | 30 | $15,612 |
| LinzessLinaclotide | 11 | $8,789 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $8,779 |
| Potassium Chloride | 200 | $4,383 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $2,910 |
| Clorazepate Dipotassium | 18 | $2,884 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $767 | $131,024125 claims |
| PfizerEliquis | $256 | $86,32980 claims |
| Novo NordiskOzempic, Rybelsus | $619 | $66,86459 claims |
| AstraZenecaFarxiga | $709 | $37,93134 claims |
| Boehringer IngelheimJardiance | $144 | $23,74615 claims |
| Johnson & JohnsonXarelto | $18 | $16,94413 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $261 | $15,61230 claims |
| AbbVieLinzess | $566 | $8,78911 claims |
| GSKTrelegy Ellipta | $34 | $8,77914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,941 family providers in Illinois.
Other family in Pinckneyville
- Ruth CarricoChicago$582K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Brooke KennardBloomington$208K
- Amy BrownellElk Grove Village$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.